scispace - formally typeset
J

Jong Sun Park

Researcher at Seoul National University Bundang Hospital

Publications -  17
Citations -  347

Jong Sun Park is an academic researcher from Seoul National University Bundang Hospital. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications receiving 158 citations.

Papers
More filters
Journal ArticleDOI

Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases

TL;DR: Although these conditions are rare, a proportion of patients with interstitial lung diseases (ILDs) may develop a progressive-fibrosing phenotype, and identification of these patients is crucial, and requires a multidisciplinary approach, to ensure optimal diagnosis and management.
Journal ArticleDOI

Change in perception of the quality of death in the intensive care unit by healthcare workers associated with the implementation of the “well-dying law”

TL;DR: In 2018, the South Korean government implemented the "well-dying law" in 2018, which enables patients to refuse futile life-sustaining treatment (LST) after being determined as terminally ill as mentioned in this paper .
Journal ArticleDOI

Idiopathic Pulmonary Fibrosis Is Associated with Common Genetic Variants and Limited Rare Variants.

Anna L. Peljto, +113 more
TL;DR: In this article , the authors used whole-genome sequencing to investigate the role of rare variants, genome-wide, on IPF risk and found that rare variants in both TERT and RTEL1 genes were significantly associated with IPF.
Journal ArticleDOI

Clinical features and long-term prognosis of acute fibrinous and organizing pneumonia histologically confirmed by surgical lung biopsy

TL;DR: The clinical manifestations and long-term prognosis of acute fibrinous and organizing pneumonia (AFOP) are unclear as discussed by the authors , and the clinical features and prognosis are unclear.
Journal ArticleDOI

Impact of body weight change on clinical outcomes in patients with idiopathic pulmonary fibrosis receiving pirfenidone

TL;DR: In this article , the authors evaluated the impact of weight loss on outcomes in Korean patients with IPF receiving pirfenidone at a tertiary medical institution and found that weight loss appeared to be a significant risk factor for mortality in patients with idiopathic pulmonary fibrosis.